Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20070027490 A1
Publication typeApplication
Application numberUS 11/536,794
Publication dateFeb 1, 2007
Filing dateSep 29, 2006
Priority dateSep 16, 1996
Also published asUS6415178, US7218963, US20020169481
Publication number11536794, 536794, US 2007/0027490 A1, US 2007/027490 A1, US 20070027490 A1, US 20070027490A1, US 2007027490 A1, US 2007027490A1, US-A1-20070027490, US-A1-2007027490, US2007/0027490A1, US2007/027490A1, US20070027490 A1, US20070027490A1, US2007027490 A1, US2007027490A1
InventorsShlomo Ben-Haim, Nissim Darvish, Yuval Mika, Maier Fenster
Original AssigneeShlomo Ben-Haim, Nissim Darvish, Yuval Mika, Maier Fenster
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Fencing of Cardiac Muscles
US 20070027490 A1
Abstract
An apparatus for blocking the electric activity of an area of tissue, comprises circuitry (S) for creating a long non-excitatory electric signal between at least two points (R1, R2) located in the vicinity of a muscle.
Images(9)
Previous page
Next page
Claims(1)
1. Apparatus for blocking the activity of an area of a tissue comprising circuitry for creating a long non-excitatory electric potential between at least two points located in the vicinity of a muscle, of a magnitude and at a timing at which it is unable to generate a propagating action potential.
Description
    FIELD OF THE INVENTION
  • [0001]
    The present invention relates to the field of medicine. More particularly, the invention relates to means for reversibly blocking the electric activity of cells. In particular, the invention relates to a method and means for reversibly blocking the muscle activity of various muscles (also referred to hereinafter as “fencing”), including the cardiac muscle.
  • BACKGROUND OF THE INVENTION
  • [0002]
    Many activities of the human body involve the contraction of muscles. For instance, movement of the limbs, breathing activity, etc. The most complex and vital muscular activity of the human body is that of the heart, which functions as a pump and which, by contracting at the required times and in the required manner, controls the flow of blood throughout the body.
  • [0003]
    The heart is composed of different parts, which contract differently and with different timing, in order to permit the aforementioned pumping activity. The contraction of the heart is controlled by electric stimuli, which are generated at the cellular level by chemical reaction. However, it is well known in the art to control such activity, i.e., the timing of the contraction of the cardiac muscle, by the action of externally applied electric stimuli, through the so-called “pace maker”.
  • [0004]
    In a copending PCT patent application No. PCTIIL97100012, filed Jan. 8, 1997, the specification of which is incorporated herein by reference, of which the inventors herein are also inventors, there is described a method and apparatus for modifying the force contraction of at least a portion of a heart chamber, which comprises applying a non-excitatory electric field, for a predetermined period of time, at a delay after activation.
  • [0005]
    In the aforesaid PCT patent application No. PCTIIL97100012 and in another copending PCT/IL patent application of the same applicants herein, filed on the same day as the present application, entitled “Apparatus and Method for Controlling the Contractility of Muscles”, and identified as Attorney's Docket 4224/WO/97, the specification of which is incorporated herein by reference, there is described a method and apparatus for decreasing the force contraction of at least a portion of a heart chamber, which comprises applying a non-excitatory electric field, for a predetermined period of time, at a delay after activation. The ability to reduce the contractility is of importance in a variety of situations, e.g., during surgery or as an aid in healing of hibernated areas of a heart after myocardial infarct.
  • [0006]
    The mechanical activity of excitable cells is directly connected to their electric activity. This is most evident in the activity of the heart, which has a relatively complex electric functioning which is responsible for pacing, contraction of various areas of the cardiac muscle, as well as to the organized consecutive or simultaneous contraction of various zones. Any disturbance in the electric function of the cells may severely affect, or even stop mechanical activities of the cell. Conduction problems are also related to a variety of congenital and acquired diseases. A detailed discussion of such phenomena can be found, e.g., in the book by Donald M. Bers, “Excitation-Contraction Coupling and Cardiac Contractile Force”, Kluwer Academic Publishers, Dordrecut, Boston, London, 1993.
  • [0007]
    Treatment of electrical cellular malfunctioning is mainly confined to systemic treatment, such as by drugs or, in some cases with heart diseases, a pace maker may be required. Localized treatment, such as local ablation, is also sometime attempted. However, there are several conditions that cannot be treated by localized treatment, unless the activity of the relevant muscle is totally blocked for a suitable period of time, in a reversible manner. One example of such a condition is ventricular fibrillation or ventricular tachycardia arrhythmias, which can be induced by abnormal activity localized in a susceptible area.
  • [0008]
    Another important tool in heart therapy is the use of defibrillators. Defibrillation is a process in which an electronic device helps reestablish normal contraction rhythms in a heart that is not functioning properly, by delivering an electric shock to the heart. Defibrillators can be external or internal (implanted or inserted). Typically, a defibrillator is designed to automatically detect episodes of bradycardia, ventricular tachycardia (VI′), fast ventricular tachycardia (FVT), and ventricular fibrillation (VF). When an arrhythmia is detected, the device will deliver the programmed pacing, cardioversion or defibrillation therapy. The device typically has two electrodes which are implanted. The defibrillator, as said, stops arrhythmia by delivering an electric shock, which is a painful and harmful treatment, particularly if repeated often and, importantly, it is not a localized treatment, but rather it is applied to the whole cardiac muscle.
  • [0009]
    It has now been surprisingly found, and this is an object of the present invention, that it is possible to block the activity of a localized area of cells, such as a muscle (i.e., to carry out a “fencing”), in a reversible manner, and thus to block the cell's activity for a desired period of time.
  • [0010]
    It is an object of the invention to provide apparatus for carrying out the fencing of a desired tissue area having electric activity and thereby temporarily and reversibly blocking the activity of said area.
  • [0011]
    It is another object of the invention to provide a method for treating a patient suffering from a condition treatable by temporarily blocking the electric activity of a tissue.
  • [0012]
    It is yet another object of the invention to provide a method and apparatus conditions, such as epilepsy, arrhythmia, stooping ticks, and shockless defibrillation.
  • [0013]
    Other objects and advantages of the invention will become apparent as the description proceeds.
  • SUMMARY OF THE INVENTION
  • [0014]
    In one aspect, the invention relates to apparatus for blocking the electric activity of an area of a tissue comprising circuitry for creating a long non-excitatory electric potential (LNT} between at least two points located in the vicinity of a muscle.
  • [0015]
    According to a preferred embodiment of the invention, the apparatus comprises circuitry for controlling the start time of the electric potential generated between said at least two points. According to another preferred embodiment of the invention, the apparatus comprises circuitry for controlling the duration of the electric potential generated between said at least two points. According to still another preferred embodiment of the invention, the apparatus comprises circuitry for controlling the magnitude of the electric potential generated between said at least two points.
  • [0016]
    The apparatus of the invention is particularly useful when the tissue on which it is employed is a cardiac muscle.
  • [0017]
    According to a preferred embodiment of the invention, the circuitry for creating a long non-excitatory electric potential between said at least two points comprises one or more electrode, e.g., carbon electrodes.
  • [0018]
    According to another preferred embodiment of the invention, the apparatus comprises circuitry for causing a long non-excitatory electric current to flow between at least two points located in the vicinity of a muscle.
  • [0019]
    The apparatus of the invention is useful, inter alia, for performing heart surgery, and comprises circuitry for creating a long non-excitatory electric potential between at least two points located in the vicinity of the cardiac muscle. According to another preferred embodiment of the invention, the apparatus comprises circuitry for causing a long non-excitatory electric current to flow between at least two points located in the vicinity of the cardiac muscle.
  • [0020]
    Illustrative examples of heart surgery in which the device of the invention can be utilized are a bypass operation and other minimal invasive cardiac operation.
  • [0021]
    The invention is further directed to a method for blocking the mechanical non-excitatory electric potential between at least two points located in the vicinity of the tissue, and controlling one or more of the parameters consisting of start time, duration, magnitude and polarity of the long non-excitatory electric potential created between said at least two points. According to a preferred embodiment of the invention, the method for blocking the electric activity of an area of a tissue comprises causing a long non-excitatory electric current to flow between at least two points located in the vicinity of the tissue, and controlling one or more of the parameters consisting of start time, duration, magnitude and polarity of the long non-excitatory electric current flowing between said at least two points.
  • [0022]
    The invention also encompasses a method for performing heart surgery, comprising blocking the mechanical and/or electric activity of a treated area of the cardiac muscle, by creating a long non-excitatory electric signal between at least two points located in the vicinity of the muscle, and controlling one or more of the parameters consisting of start time, duration, magnitude and polarity of said long non-excitatory electric signal, thereby to obtain the desired blocking of the mechanical and/or electric activity of the cardiac muscle at the treated heart area and thereafter performing surgery thereon.
  • [0023]
    In one aspect, the invention is directed to a method for blocking the mechanical and/or electric activity of an area of a tissue, comprising:
  • [0024]
    providing means for creating an electric potential between at least two points located in the vicinity of said area of the tissue;
  • [0025]
    providing means for causing a non-excitatory electric current to flow between said at least two point; and
  • [0026]
    controlling the start time, duration and magnitude of the electric current flowing between said at least two points, such that the total duration of the long non-excitatory electric signal exceeds the threshold value at which the activity of the tissue is blocked.
  • [0027]
    In another aspect the invention is directed to a method of treating a condition induced by electric activity of cells, comprising treating a patient in need thereof with the application of a long non-excitatory signal between at least two points located in the vicinity of the affected cells, such that the total duration of the long non-excitatory electric signal exceeds the threshold value at which the electric activity of the tissue is blocked.
  • [0028]
    According to a preferred embodiment of the invention, the apparatus comprises the means for controlling the start time, duration and magnitude of the electric current flowing between said at least two points located in the vicinity of an area of the tissue comprise pulse generating means for generating a plurality of pulses, with a given frequency, and wherein the timing of said pulses is adapted to the activity of the tissue, the total duration of said series of pulses constituting the duration of the long non-excitatory signal.
  • [0029]
    The invention is also directed to defibrillating apparatus comprising circuitry for creating a long non-excitatory electric potential between at least two points located in the vicinity of a muscle, and to a method for carrying out a defibrillation in a patient in need thereof, comprising blocking the electric activity of an area of a tissue, comprising creating a long non-excitatory electric potential between at least two points located in the vicinity of the tissue, and controlling one or more of the parameters consisting of start time, duration, magnitude and polarity of the long non-excitatory electric potential created between said at least two points until defibrillation is achieved. According to a preferred embodiment of the invention, the method comprises causing a long non-excitatory electric current to flow between at least two points located in the vicinity of the tissue, and controlling one or more of the parameters consisting of start time, duration, magnitude and polarity of the long non-excitatory electric current flowing between said at least two points until defibrillation is achieved.
  • [0030]
    As will be apparent to the skilled person, the LNT-signal must be timed so as to have a delay relative to the activity of the muscle. If this is not taken into account a deleterious effect may result. For instance, when the cardiac muscle is treated, fibrillation may be induced by an electric signal which not properly timed. Additionally, the LINT″-signal will typically be composed of a plurality of short peaks, applied at a given frequency, and the total length of time during which said short peaks are applied constitutes the total duration of the LNT-signal. In order to deal with the above needs, in a preferred embodiment of the invention the means for controlling the start time, duration and magnitude of the electric current flowing between said at least two points located in the vicinity of an area of the tissue, comprise pulse generating means for generating a plurality of pulses, with a given frequency, and wherein the timing of said pulses is adapted to the activity of the tissue, the total duration of said series of pulses constituting the duration of the long non-excitatory signal.
  • [0031]
    According to a preferred embodiment of the invention there is provided a defibrillating apparatus for the localized and selective defibrillation at one or more locations of a heart, comprising for each of said one or more locations:
  • [0032]
    sensing means for sensing a change in electric activity of the heart or of a portion thereof;
  • [0033]
    analyzing circuitry, for analyzing said change in electric activity;
  • [0034]
    logic circuitry, for deciding on the appropriate therapy to he delivered to the sensed area or to the area of the heart which is responsible for the change in electric activity, said appropriate therapy comprising the application to the affected area of a long non-excitatory signal of a suitable magnitude, start time, duration and frequency;
  • [0035]
    signal delivery means, for delivering said long non-excitatory signal to said area of the heart; and
  • [0036]
    control means, for controlling the delivery of said long non excitatory signals to each affected area, and for timing the delivery of different signals to two or more different affected areas of the heart.
  • [0037]
    The signal delivery means can be of various suitable types and may include, e.g., one or more electrodes.
  • [0038]
    In the context of the present invention, by “long non-excitatory current”, or “long non-excitatory potential”, or “long non-excitatory signal”, it is meant to indicate a signal which does not cause a propagating action potential in the muscle cells (which may start a new pacing or contraction of the muscle). In other words, the non-excitatory electric stimulation effected by a non-excitatory electric pulse is such that it does not induce propagating activation potentials in the cardiac muscle cells. Rather, such pulses affect the response of the heart muscle to the action potentials, by affecting cell electrical characteristics within selected segments of the cardiac muscle.
  • [0039]
    As described in the abovementioned PCT patent application PCTIIL07/00012, while a DC current is typically used as the base line for the non-excitatory signal, it is also possible to supply a signal which is a complex signal, for instance, a signal generated by superimposing an AC current on the DC base signal, so as to generate a waveform of varying envelope. Any suitable signal can be superimposed, having any shape, e.g., square wave or sinusoidal wave, as will be apparent to the skilled person. Thus, according to one preferred embodiment of the invention the apparatus further comprises means for superimposing on a DC signal one or more waveforms of given frequency and amplitude, thereby to generate a complex signal.
  • [0040]
    The apparatus can be provided in various forms, depending on the specific needs. One example of apparatus suitable for carrying out the invention is described in detail and claimed in a copending PCT patent application of the same applicants herein, entitled “Cardiac Output Controller”, filed on the same day as the present. application and identified as Attorney's Docket 27068, the description of which is incorporated herein by reference. Another example of suitable apparatus, coupled to a pacemaker device, is the subject of another copending PCT patent application of the same applicants herein, entitled “Cardiac Output Enhanced Pacemaker”, filed on the same day as the present application and identified as Attorney's Docket 27181, the specification of which is also incorporated herein by reference. However, as said, the invention is not intended to be limited to any particular construction of device used to carry it out.
  • [0041]
    According to a preferred embodiment of the invention, the apparatus is intended for long term treatment, and is an insertable device. An insertable device is a device which can be introduced for a limited period of time (i.e. up to a few weeks), for a prolonged therapy. It differs from an implanted device inasmuch as it is not meant to be carried by the patient indefinitely or for very long periods of time. According to another preferred embodiment the apparatus can be implantable. According to still another preferred embodiment of the invention, the apparatus, whether intended for short or long term treatment, is an extra corporal device.
  • [0042]
    As explained above, the means for causing a non-excitatory DC electric current to flow, are preferably synchronized to heart activity. According to a preferred embodiment of the invention, the means for causing a non-excitatory DC electric current to flow operate not at every beat of the heart, e.g., operate every 1, 2 or 3 beats of the heart.
  • [0043]
    As will be appreciated by the skilled person, the actual set of operating parameters used (current, length of pulse, number of electrodes, lag after pacing signal, etc.), will be dependent on the specific use made of the invention, and the skilled person will easily be able to devise the optimal set of parameters for a given application. Where no pace maker is used, the delay is preferably calculated from the natural activity of the patient's heart, or from the local electrical activity.
  • [0044]
    The invention can be conveniently carried out using sensing means coupled to control means, which sense the electric activity of the muscle and activate the LNT-signal at the appropriate time.
  • [0045]
    It should further be noted that, while in the above discussion and in the examples to follow particular emphasis has been put on cardiac muscles, this has been done only for the purpose of illustration, and the invention is by no means meant to be limited in any way to cardiac muscle. On the contrary, the invention is applicable to other tissue which has an activity which is dependent on electric signals.
  • [0046]
    While a variety of electrodes can be used, and the invention is in no way limited to any particular type of electrode, particularly preferred suitable electrodes for this purpose are, e.g., carbon electrodes.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0047]
    The above and other characteristics and advantages of the invention will be more readily apparent through the following detailed description of preferred embodiments thereof, with reference to the appended drawings, wherein:
  • [0048]
    FIGS. 1-7 show the effect of the application of an LNT-signal to a rabbit papillary muscle, under varying conditions; and
  • [0049]
    FIG. 8 is a schematic representation of an apparatus according to one embodiment of the invention.
  • DEFINITIONS
  • [0050]
    The following terms and abbreviations, used throughout this specification, are defined below, for the sake of clarity:
  • [0051]
    I.M.=Intramuscular
  • [0052]
    IV=Intra Venous
  • [0053]
    LV=Left Ventricle
  • [0054]
    RV=Right Ventricle
  • [0055]
    VF=Ventricular Fibrillation
  • DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
  • [0056]
    The invention will now be illustrated through detailed experiments. Experiments in vitro were carried out using isolated rabbit papillary muscle, and the protocol for its isolation is detailed below.
  • Equipment
  • [0057]
    The following equipment which will be referred to hereinafter, is now briefly described for the sake of clarity:
  • [0058]
    Plugsvs system: The plugsys system is an incorporating plug in nodules for measuring, controlling and data processing in connection with recorders and computers. In general, it functions as an amplifier which increases the sensitivity of the measuring of biological signals. One such device, used in the experiments described herein, is manufactured by HSE, Germany.
  • [0059]
    Millar: This device (manufactured by Millar Instruments, USA), is a micro manometers transducer that can be connected to a battery operated bridge (which is the interface box) and the output can be digitized using an AI3 converter. In another mode of operation the transducer is connected through a DBA (plugsys DC Bridge Amplifier), which is an amplifier connected to transducers to measure pressure force (manufactured by ESE, Germany).
  • Isolated Papillary Muscle Protocol
  • [0060]
    Animals: New Zealand white rabbits (males) from Israel Tokneam) or an hybrid of New Zealand White and local albino rabbits (males, AniLab, Rehovot) are kept in room temperature, 2-3 per cage (355565 cm), under natural light conditions. Daily feeding of dry food (Rabbit Mix-Code 590), and unlimited water supply. The cages and the room are cleaned daily,
  • Instruments
  • [0061]
    A. for solution making: Scales (by Mettler Toledo, model P8303, Max 310 gram, d=1 rnGram) magnetic stirrer. by Freed electric. Weights 10 Kg (d=5O gram) by Moznei Shekel, Gas tanks with mixed 95% 02+5% C02” pressure regulators, pH meter by Mettler Toledo, model 320 PH, ice machine 45 Labotal.
  • [0062]
    Dissection chamber (HSE, Hugo Sachs Elektroniic, Germany), Steered organ bath type 813 (1-18E) including temperature controller type 319, Force Transducer type F30 with amplier type 660 and calibration unit (HSE), Stereoscope (Olympus, Japan), Digital micro manipulator (HSE), Manipulator, 1sin˜ti-vibration table (TMC, USA), Faraday cage, Fiber optic illuminator (HSE), Current and Voltage clamp amplifier (axon Instruments, USA), stimulators (grass instruments, USA), Micro-pipette puller model pp-83 (Narishige, Japan) Current source ISO 10 and ISO −50 (home made) supplying 10 and 50 mA correspondingly and Oscilloscope, 20 MHz (Gould, England), Computers: PowerPC 9500/150, (Apple, USA), or Pentium, 166 MHz, Data Acquisition Boards: PCI-MIO-16XE50, 16 bite, or the PCI-MIO-16E-2, 12 bite board by National Instrument, software: LabView for windows, by National Instrument (USA). Data acquisition and analysis program are home made, The program includes data acquisition and on-line analysis, programmable experiment execution, programmable signal output. The off line analysis program analyze different parameters of muscle twitch and action potentials.
  • Solution
  • [0063]
    The Krebs-Heseleit Solution (KHS) was prepared using materials from Sigma (Israel): 0.32 gllit KCl (4.5 mM), 6.99 gllit NaCl (118.0 mM), 2.01 gllit NaHCO:s (24.0 mM), 0.285 gllit MgSO407H2O (1.19 mM), 0.16 gllit KH2P04 (1.18 mM), 2.0 at Glucose (11.0 mM), and 0.37 gllit CaCl2.2H2O (2.52 mM), added after bubbling with a 95% 02+5% CO2 gas mixture for 20 minutes.
  • [0064]
    Solution preparation: Distilled water (ion exchange column Zilion, Israel and ultra filtration by EasypurLF, Israel) are used to prepare the KHS stock solution (X 20, 5 L). The chemicals except Ca012 are used. The stock solution is discarded after 1 week of refrigeration, For each day of experiment fresh solution is prepared (5 L) out of the stock solution, CaClh is added, and the solution is bubbled (95% O A % C02) for 20 min. and titrated to a pH of 7.4. Bubbled KHS at room temperature is used for perfusion of the papillary muscle kept in an organ bath.
  • [0065]
    Anesthesia and heart dissection: animal is brought from the cage to a scale for measuring body weight, The animal is anesthetized by 1 Vemhutal 1-1.2 mg/Kg body weight I.P, using −5 cc syringe and 23 Gage needle. The level of anesthesia is checked by the animal reflex to a pinch. When the animal is deeply anesthetized, the skin over the chest is cut off and the chest wall is cut open exposing the heart. Using scissors and a forceps the pericardium is cut and the heart is dissected out by cutting all the blood vessels, Immediately after cutting, the heart is placed in an ice cold (4 C.) and oxygenated KHS.
  • [0066]
    Papillary muscle dissection: The heart is transferred to a fresh ice-cold M S and than to the dissection chamber, containing ice-cold continuously oxygenated KHS. The heart is fixed to a rubber pad with insect pins and than the left ventricle is opened exposing the papillary muscles. A silk (6 0) thread is tied around the tendon of the papillary muscle and the muscle is dissected out using fine twizers. The dissected muscle (length of 2-3 mm) is transferred to the organ bath and the heart is kept at 4 C. for further dissections of the other papillary muscles.
  • [0067]
    The Steiert Organ Bath: The muscle is placed in an organ bath, and than fixed to the chamber by a plastic holder. The silk thread tied to the tendon is hooked to a rigid hook on the force transducer (on the opposite side) to give isometric conditions. The papillary muscle is continuously perfused (7-22 mllmin,) with oxygenated M S kept at a regulated temperature of 37 C.
  • Pacing and Stimulation
  • [0068]
    Pacing stimuli (typically 1 Hz, 2 ms duration, and amplitude of 2 mA) are given by two Ag—AgCI electrodes which are part of the organ bath and are placed under the muscle. The electrodes are covered with AgCI layer, chlorodizing by 5, 5 ms pulses during perfusion. Constant current stimuli (CCU) are given to the upper part of the muscle using graphite electrodes (diameter of 0.5 mm fitted to a glass pipette) placed 2-3 mm apart along the fibers' line(contraction axis). The muscle length is adjusted to maximal isometric force and left for equilibration period of 30 min.
  • EXAMPLE 1 Temporary and Reversible Electrical Block
  • [0069]
    A rabbit papillary muscle was paced using a pacing signal of 2 mS duration at 1 Hz, and 8 mA amplitude (twice the threshold measured for that muscle). An LNT-signal was applied 1 mS delay after the pacing signal, having a duration of 998 mS and an amplitude of 6 mA. The resulting effect is shown in FIG. 1.
  • [0070]
    It can be seen from FIG. 1 that the electrical muscle activity was totally blocked by the LNT signal from responding to the pacing signal, and thus contraction of the muscle was inhibited. Total recovery of the muscle electrical activities seen after the end of the application of the LNT signal.
  • EXAMPLE 2 Mechanical Block
  • [0071]
    A rabbit papillary muscle was paced using a pacing signal of 2 mS duration at 1 Hz, and 2.2 mA amplitude, and an LNT-signal was applied 400 mS after the pacing signal, with duration of 200 mS and amplitude of 0.5 mA, The polarity of the LNT-signal was inverted during the experiment (polarity direction in the figures is arbitrary, since there is no absolute “+” and “−” signs for the LNT signal, and the suitable polarity is established for each specific case).
  • [0072]
    As seen in FIG. 2, the initial inverse signal is an excitatory signal, and as such it causes corresponding contractions in the muscle, indicated by the intervening peaks between the response to the pacing signal, and no blocking of the contraction muscle activity occurs. When the polarity is switched, however, to be as in FIG. 1, blocking of the muscle activity is achieved.
  • EXAMPLE 3
  • [0073]
    A rabbit papillary muscle was paced using a pacing signal of 2 mS duration at 1 Hz, and 3 m,A amplitude. The above pacing parameters are twice of the relative threshold values needed for evoking a contraction in this muscle. An LNT-signal was applied after 1 mS of the pacing signal, having a duration of 998 mS and an amplitude of 15 mA. The resulting effect is shown in FIG. 3.
  • [0074]
    As is seen in FIG. 3, total block of the muscle activity was initially obtained, followed by a casual escape from that block, which was not repeatable and which appears to be due to an occasional experimental problem. As is seen in the figure, stopping the pacing signal did not result in contractions, even though the LNT-signal employed was 5 times greater in amplitude than the pacing signal. This result, again, indicates that the LNT-signal is a non-excitatory signal in its nature, and that activity of the muscle was completely blocked. Upon termination of the LNT-signal the muscle returned to normal rhythm contraction. A residual effect on muscle contraction can be seen on the muscle during recovery, for several minutes.
  • EXAMPLE 4
  • [0075]
    A rabbit papillary muscle was paced using a pacing signal of 2 mS duration at 1 Hz, and 3 mA amplitude. The above pacing parameters are twice the relative threshold values for the muscle employed. An LNT-signal was applied after 1 mS of the pacing signal, having a duration of 998 mS and an amplitude of 15 mA. The resulting effect is shown in FIG. 4. The muscle activity was totally blocked.
  • EXAMPLE 5
  • [0076]
    Rabbit papillary muscle was paced with the following parameters: 0.5 Hz, 2 mS duration, &5 mA; and LNT-Signal was applied at 1 mS delay, duration, 15 mA, 0.5 Hz.
  • [0077]
    The results show a complete blocking of muscle activity (FIG. 5), and recovery of the muscle is observed after turning off the LNT signal.
  • EXAMPLE 6
  • [0078]
    Example 1 was repeated, using the following parameters:
  • [0079]
    Pacing: 1 Hz. 2 mS duration, 3 mA (these parameters are twice the threshold measured for this muscle);
  • [0080]
    LNT•Signal: 1 mS delay, 998 mS duration, 5 mA, 1 Hz.
  • [0081]
    A blow-up of one action potential resulting from a pacing signal superimposed on the potential measured when both pacing and LNT signals were applied is shown in FIG. 6, Application of the LNT-signal resulted in a total block of cell action potential, measured by an intercellular electrode (thin line in the figure).
  • [0082]
    Thick line: action potential as a result of pacing signal only.
  • [0083]
    Thin line: superimposing of the changes in membrane potential during LNT-signal application, showing that a cell failed to respond by a new action potential to the pacing signal.
  • [0084]
    This experiment shows that the LNT-signal blocked all muscle activity.
  • EXAMPLE 7
  • [0085]
    Example 1 was repeated, using the following parameters:
  • [0086]
    Pacing: 1 Hz, 2 mS duration, 3 mA (these parameters are twice the threshold measured for this muscle);
  • [0087]
    LW-Signal: 1 mS delay, 998 mS duration, 15 mA, 1 Hz,
  • [0088]
    The results are shown in FIG. 7. Application of the LNT-signal (downward deflection) resulted in a total block of muscle electrical activity, measured by an intercellular electrode, and of the contraction activity of the muscle, At the end of the NT-signal the potential and the contraction force undergo full recovery. This result shows that the LNT-signal blocked all mechanical and electrical activity.
  • [0089]
    Referring now to FIG. 8, a schematic representation of an apparatus according to one embodiment of the invention is seen. In this scheme, a portion of a cardiac muscle, H, is brought into closed positioned relationship with two electrodes, E1 and E2, the ends of which are positioned at root position R1 and R2, respectively. The electrodes receive the voltage and/or current from a signal generator S, the construction of which is conventional and well know to skilled persons, and which is therefore not described here in detail, which in turn receives power from a power line, PL, connected to an autonomous power source or to the mains, as the case may be. Illustrative examples of suitable apparatus may be found, e.g., in the aforesaid copending PCTIIL patent applications entitled “Cardiac Output Controller” (Attorney's Docket 27068), and “Cardiac Output Enhanced Pacemaker” (Attorney's Docket 27181), both filed on the same day as the present application, the specifications of which are incorporated herein by reference, The activity of the power signal generator S is controlled by a controller, C, which may be a microprocessor, or which may be an external controlling device, e.g., a P C or other computer. The controller C controls the parameters of the signal generated by the signal generator, such as current intensity, frequency and timing, and may use both preset parameters (e.g., the frequency of pulse generation) and feed-back input, e.g., from apparatus which monitors heart or other parameters, or from a pace maker which supplies the pacing signal. These input signals are collectively schematically indicated in the figure as FB. Of course, the apparatus is only schematically shown, for the sake of brevity. And the skilled person will easily be able to devise many different kinds of apparatus suitable to supply the signal needed in carrying out the invention.
  • [0090]
    All the above description and examples have been given for the purpose of illustration and are not intended to limit the invention in any way. Many modifications can be carried out in the invention: for instance, many different tissues and different conditions can be treated; furthermore, different LNT-signals can be employed, all without exceeding the scope of the invention.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3572345 *Jan 27, 1969Mar 23, 1971Philips CorpStrap for a heart stimulator
US3587567 *Dec 20, 1968Jun 28, 1971Schiff Peter PaulMechanical ventricular assistance assembly
US3651805 *May 7, 1970Mar 28, 1972Draegerwerk AgAnesthetic vaporizer
US3651806 *Oct 24, 1969Mar 28, 1972Philip I HirshbergMethod and apparatus for administering digitalizing medications
US3933147 *Apr 2, 1970Jan 20, 1976Vall Wilbur E DuApparatus and method for treating disorders in the region of the pubococcygeous muscle
US3942536 *Sep 19, 1973Mar 9, 1976Mieczyslaw MirowskiCardioverting device having single intravascular catheter electrode system and method for its use
US3952750 *Apr 25, 1974Apr 27, 1976Mieczyslaw MirowskiCommand atrial cardioverting device
US4030509 *Sep 30, 1975Jun 21, 1977Mieczyslaw MirowskiImplantable electrodes for accomplishing ventricular defibrillation and pacing and method of electrode implantation and utilization
US4106494 *Aug 29, 1977Aug 15, 1978American Optical CorporationHeart defibrillating and monitoring system
US4184493 *Feb 15, 1978Jan 22, 1980Mieczyslaw MirowskiCircuit for monitoring a heart and for effecting cardioversion of a needy heart
US4202340 *Feb 15, 1978May 13, 1980Mieczyslaw MirowskiMethod and apparatus for monitoring heart activity, detecting abnormalities, and cardioverting a malfunctioning heart
US4223678 *May 3, 1978Sep 23, 1980Mieczyslaw MirowskiArrhythmia recorder for use with an implantable defibrillator
US4273114 *Nov 23, 1979Jun 16, 1981Michigan Instruments, Inc.Cardiopulmonary resuscitator, defibrillator and monitor
US4312354 *Feb 4, 1980Jan 26, 1982Arco Medical Products CompanyPacemaker with circuit for pulse width modulating stimulus pulses in accordance with programmed parameter control states
US4316472 *Aug 9, 1979Feb 23, 1982Mieczyslaw MirowskiCardioverting device with stored energy selecting means and discharge initiating means, and related method
US4337776 *Aug 29, 1980Jul 6, 1982Telectronics Pty. Ltd.Impedance measuring pacer
US4384585 *Mar 6, 1981May 24, 1983Medtronic, Inc.Synchronous intracardiac cardioverter
US4387717 *Oct 3, 1980Jun 14, 1983Research CorporationPacer internal cardiac electrogram sensing system
US4403614 *Feb 27, 1981Sep 13, 1983Medtronic, Inc.Implantable cardioverter
US4407288 *Mar 16, 1981Oct 4, 1983Mieczyslaw MirowskiImplantable heart stimulator and stimulation method
US4411268 *Feb 10, 1982Oct 25, 1983Medtronic, Inc.Muscle stimulator
US4440172 *Dec 11, 1980Apr 3, 1984Mieczyslaw MirowskiApparatus for combining pacing and cardioverting functions in a single implanted device
US4543956 *May 24, 1984Oct 1, 1985Cordis CorporationBiphasic cardiac pacer
US4566456 *Oct 18, 1984Jan 28, 1986Cordis CorporationApparatus and method for adjusting heart/pacer rate relative to right ventricular systolic pressure to obtain a required cardiac output
US4572191 *Feb 23, 1984Feb 25, 1986Mieczyslaw MirowskiCommand atrial cardioverter
US4651716 *Nov 1, 1985Mar 24, 1987Canadian Patents And Development LimitedMethod and device for enhancement of cardiac contractility
US4674508 *May 28, 1985Jun 23, 1987Cordis CorporationLow-power consumption cardiac pacer based on automatic verification of evoked contractions
US4679572 *Mar 11, 1986Jul 14, 1987Intermedics, Inc.Low threshold cardiac pacing electrodes
US4690155 *Dec 24, 1986Sep 1, 1987Cordis CorporationMonophasic action potential recording lead
US4726379 *Nov 14, 1985Feb 23, 1988Cardiac Control Systems, Inc.Cardiac pacer with switching circuit for isolation
US4765341 *Aug 25, 1983Aug 23, 1988Mieczyslaw MirowskiCardiac electrode with attachment fin
US4830006 *Jun 17, 1986May 16, 1989Intermedics, Inc.Implantable cardiac stimulator for detection and treatment of ventricular arrhythmias
US4928688 *Jan 23, 1989May 29, 1990Mieczyslaw MirowskiMethod and apparatus for treating hemodynamic disfunction
US4998531 *Mar 28, 1990Mar 12, 1991Cardiac Pacemakers, Inc.Implantable N-phasic defibrillator output bridge circuit
US5002052 *Aug 29, 1988Mar 26, 1991Intermedics, Inc.System and method for detection and treatment of ventricular arrhythmias
US5003976 *Sep 28, 1988Apr 2, 1991Eckhard AltCardiac and pulmonary physiological analysis via intracardiac measurements with a single sensor
US5020544 *Nov 1, 1989Jun 4, 1991Cardiac Pacemakers, Inc.Low energy defibrillation electrode
US5022396 *Dec 12, 1989Jun 11, 1991Hideto WatanabeCatheter for simultaneously measuring monophasic action potential and endocardiac cavity pressure
US5026397 *Sep 10, 1990Jun 25, 1991Kabushiki Kaisya Advance Kaihatsu KenkyujoTranscutaneously implantable element
US5044375 *Dec 8, 1989Sep 3, 1991Cardiac Pacemakers, Inc.Unitary intravascular defibrillating catheter with separate bipolar sensing
US5083564 *Jun 1, 1990Jan 28, 1992Board Of Regents Of The University Of OklahomaMethod for alleviating and diagnosing symptoms of heart block
US5085218 *Aug 31, 1990Feb 4, 1992Cardiac Pacemakers, Inc.Bipolar myocardial positive fixation lead with improved sensing capability
US5097832 *Mar 9, 1990Mar 24, 1992Siemens-Pacesetter, Inc.System and method for preventing false pacemaker pvc response
US5111815 *Oct 15, 1990May 12, 1992Cardiac Pacemakers, Inc.Method and apparatus for cardioverter/pacer utilizing neurosensing
US5129394 *Jan 7, 1991Jul 14, 1992Medtronic, Inc.Method and apparatus for controlling heart rate in proportion to left ventricular pressure
US5156147 *Feb 5, 1991Oct 20, 1992Cardiac Pacemakers, Inc.Variable rate pacemaker having upper rate limit governor based on hemodynamic performance
US5156149 *Jan 30, 1992Oct 20, 1992Medtronic, Inc.Sensor for detecting cardiac depolarizations particularly adapted for use in a cardiac pacemaker
US5199428 *Mar 22, 1991Apr 6, 1993Medtronic, Inc.Implantable electrical nerve stimulator/pacemaker with ischemia for decreasing cardiac workload
US5205284 *Jun 12, 1990Apr 27, 1993Zoll Medical CorporationMethod and apparatus for transcutaneous electrical cardiac pacing with background stimulation
US5213098 *Jul 26, 1991May 25, 1993Medtronic, Inc.Post-extrasystolic potentiation stimulation with physiologic sensor feedback
US5233985 *Jul 15, 1991Aug 10, 1993Medtronic, Inc.Cardiac pacemaker with operational amplifier output circuit
US5284491 *Feb 27, 1992Feb 8, 1994Medtronic, Inc.Cardiac pacemaker with hysteresis behavior
US5305745 *Apr 2, 1992Apr 26, 1994Fred ZacoutoDevice for protection against blood-related disorders, notably thromboses, embolisms, vascular spasms, hemorrhages, hemopathies and the presence of abnormal elements in the blood
US5320642 *Jan 22, 1992Jun 14, 1994Board Of Regents For The University Of OkMethod for alleviating and diagnosing symptoms of heart block
US5320643 *Oct 6, 1992Jun 14, 1994Medtronic, Inc.Automatic cardiac capture restoration and threshold-seeking method and apparatus
US5324327 *Dec 17, 1991Jun 28, 1994Cohen Donald MLow threshold cardiac pacing lead
US5327887 *Jan 25, 1993Jul 12, 1994Ludwik NowakowskiCardiopulmonary resuscitation device
US5346506 *Nov 10, 1992Sep 13, 1994Mower Morton MMethod for establishing defibrillation threshold for a cardiac defibrillator
US5353800 *Dec 11, 1992Oct 11, 1994Medtronic, Inc.Implantable pressure sensor lead
US5387419 *Mar 26, 1993Feb 7, 1995The University Of MichiganSystem for controlled release of antiarrhythmic agents
US5391192 *Mar 4, 1994Feb 21, 1995Telectronics Pacing Systems, Inc.Automatic ventricular pacing pulse threshold determination utilizing an external programmer and a surface electrocardiogram
US5391199 *Jul 20, 1993Feb 21, 1995Biosense, Inc.Apparatus and method for treating cardiac arrhythmias
US5417717 *May 16, 1994May 23, 1995Cardiac Pacemakers, Inc.Implantable cardiac function monitor and stimulator for diagnosis and therapy delivery
US5431688 *Jul 19, 1993Jul 11, 1995Zmd CorporationMethod and apparatus for transcutaneous electrical cardiac pacing
US5433730 *Oct 7, 1993Jul 18, 1995Intermedics, Inc.Conductive pouch electrode for defibrillation
US5443485 *Sep 8, 1993Aug 22, 1995Intermedics, Inc.Apparatus and method for capture detection in a cardiac stimulator
US5447520 *Mar 29, 1994Sep 5, 1995The Regents Of The University Of CaliforniaReal time stabilizing system for pulsating activity
US5531764 *Apr 14, 1994Jul 2, 1996Angeion CorporationImplantable defibrillator system and method having successive changeable defibrillation waveforms
US5540722 *May 16, 1994Jul 30, 1996Physiometrix, Inc.Switch apparatus and method for switching between multiple electrodes for diagnostic and therapeutic procedures
US5556421 *Feb 22, 1995Sep 17, 1996Intermedics, Inc.Implantable medical device with enclosed physiological parameter sensors or telemetry link
US5568809 *Jul 12, 1995Oct 29, 1996Biosense, Inc.Apparatus and method for intrabody mapping
US5601609 *Mar 14, 1995Feb 11, 1997Pacesetter, Inc.Implantable cardiac stimulating device and method for administering synchronized cardioversion shock therapy to provide preemptive depolarization
US5601611 *Aug 5, 1994Feb 11, 1997Ventritex, Inc.Optical blood flow measurement apparatus and method and implantable defibrillator incorporating same
US5626622 *Sep 21, 1994May 6, 1997Telectronics Pacing Systems, Inc.Dual sensor rate responsive pacemaker
US5649966 *Feb 20, 1996Jul 22, 1997Pacesetter AbMethod and apparatus for applying electrical signals to a heart for therapy or diagnosis
US5651378 *Feb 20, 1996Jul 29, 1997Cardiothoracic Systems, Inc.Method of using vagal nerve stimulation in surgery
US5674251 *Mar 26, 1996Oct 7, 1997Medtronic, Inc.Method and apparatus for treatment of atrial fibrillation
US5674259 *Oct 20, 1993Oct 7, 1997Gray; Noel DesmondMulti-focal leadless apical cardiac pacemaker
US5713935 *Aug 23, 1996Feb 3, 1998Sulzer Intermedics Inc.Method and apparatus for monitored biphasic cardiac impedance sensing
US5720768 *May 22, 1996Feb 24, 1998Sulzer Intermedics Inc.Dual chamber pacing with interchamber delay
US5735876 *Oct 25, 1995Apr 7, 1998Galvani Ltd.Electrical cardiac output forcing method and apparatus for an atrial defibrillator
US5738096 *Feb 1, 1996Apr 14, 1998Biosense, Inc.Cardiac electromechanics
US5738105 *Oct 24, 1995Apr 14, 1998Angeion CorporationMethod and apparatus for sensing R-waves using both near field and far field sensing simultaneously
US5749906 *Dec 3, 1996May 12, 1998Medtronic, Inc.Dual chamber pacing system and method with continual adjustment of the AV escape interval so as to maintain optimized ventricular pacing for treating cardiomyopathy
US5755740 *Oct 22, 1997May 26, 1998Nappholz; TiborPacemaker with automatic calibration of the response of multiple sensors
US5782876 *Apr 15, 1996Jul 21, 1998Medtronic, Inc.Method and apparatus using windows and an index value for identifying cardic arrhythmias
US5782881 *Sep 20, 1996Jul 21, 1998Lu; RichardPacemaker with safety pacing
US5792198 *Apr 21, 1997Aug 11, 1998Nappholz; Tibor A.Auto adaptation of RR interval in implantable pacemaker
US5792208 *Jun 30, 1997Aug 11, 1998Gray; Noel DomondHeart pacemaker
US5797967 *Sep 27, 1996Aug 25, 1998Cardiac Pacemakers, Inc.System and method to reduce defibrillation requirements
US5800464 *Oct 3, 1996Sep 1, 1998Medtronic, Inc.System for providing hyperpolarization of cardiac to enhance cardiac function
US5807234 *Jun 27, 1997Sep 15, 1998Pacesetter, Inc.Myostimulator control using metabolic demand and muscle performance
US5814079 *Oct 4, 1996Sep 29, 1998Medtronic, Inc.Cardiac arrhythmia management by application of adnodal stimulation for hyperpolarization of myocardial cells
US5871506 *Aug 19, 1996Feb 16, 1999Mower; Morton M.Augmentation of electrical conduction and contractility by biphasic cardiac pacing
US6041252 *Jun 7, 1995Mar 21, 2000Ichor Medical Systems Inc.Drug delivery system and method
US6136019 *Jan 16, 1998Oct 24, 2000Mower Family Chf Treatment Irrevocable TrustAugmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool
US6141587 *May 27, 1998Oct 31, 2000Mower Family Chf Treatment Irrevocable TrustAugmentation of muscle contractility by biphasic stimulation
US6236887 *Jul 9, 1997May 22, 2001Impulse Dynamics N.V.Drug-device combination for controlling the contractility of muscles
US6415178 *Jul 9, 1997Jul 2, 2002Impulse Dynamics N.V.Fencing of cardiac muscles
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US8019421Sep 13, 2011Metacure LimitedBlood glucose level control
US8244371Mar 16, 2006Aug 14, 2012Metacure LimitedPancreas lead
US8260416Sep 4, 2012Impulse Dynamics, N.V.Electrical muscle controller
US8301247Oct 30, 2012Impulse Dynamics, N.V.Electrical muscle controller
US8306616Nov 6, 2012Impulse Dynamics, N.V.Electrical muscle controller
US8306617Nov 6, 2012Impulse Dynamics N.V.Electrical muscle controller
US8311629Nov 13, 2012Impulse Dynamics, N.V.Electrical muscle controller
US8321013Nov 27, 2012Impulse Dynamics, N.V.Electrical muscle controller and pacing with hemodynamic enhancement
US8326416Oct 25, 2010Dec 4, 2012Impulse Dynamics NvApparatus and method for delivering electrical signals to modify gene expression in cardiac tissue
US8346363Jan 1, 2013Metacure LimitedBlood glucose level control
US8352031Jan 8, 2013Impulse Dynamics NvProtein activity modification
US8548583May 4, 2006Oct 1, 2013Impulse Dynamics NvProtein activity modification
US8655444Oct 29, 2012Feb 18, 2014Impulse Dynamics, N.V.Electrical muscle controller
US8666495Mar 18, 2005Mar 4, 2014Metacure LimitedGastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US8700161Sep 4, 2003Apr 15, 2014Metacure LimitedBlood glucose level control
US8792985Jan 20, 2006Jul 29, 2014Metacure LimitedGastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US8825152Apr 3, 2002Sep 2, 2014Impulse Dynamics, N.V.Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue
US8934975Feb 1, 2011Jan 13, 2015Metacure LimitedGastrointestinal electrical therapy
US8958872Feb 17, 2014Feb 17, 2015Impulse Dynamics, N.V.Electrical muscle controller
US8977353Aug 20, 2013Mar 10, 2015Impulse Dynamics NvProtein activity modification
US9101765Feb 16, 2006Aug 11, 2015Metacure LimitedNon-immediate effects of therapy
US9186514Feb 13, 2015Nov 17, 2015Impulse Dynamics NvElectrical muscle controller
US9289618Oct 23, 2001Mar 22, 2016Impulse Dynamics NvElectrical muscle controller
US20030040777 *Apr 3, 2002Feb 27, 2003Itzik ShemerModulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue
US20030055464 *Sep 5, 2002Mar 20, 2003Nissim DarvishBlood glucose level control
US20040249421 *Mar 18, 2004Dec 9, 2004Impulse Dynamics NvBlood glucose level control
US20060085045 *Sep 4, 2003Apr 20, 2006Metacure N.V.Blood glucose level control
US20060184207 *Dec 27, 2005Aug 17, 2006Metacure N.V.Blood glucose level control
US20070027493 *Jan 20, 2006Feb 1, 2007Shlomo Ben-HaimGastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US20070239216 *Apr 3, 2002Oct 11, 2007Itzik ShemerModulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue
US20080037033 *Jun 13, 2005Feb 14, 2008Isra Vision Systems AgSensor For Measuring The Surface Of An Object
US20080058879 *Oct 31, 2007Mar 6, 2008Shlomo Ben-HaimElectrical Muscle Controller
US20080140142 *Oct 31, 2007Jun 12, 2008Nissim DarvishElectrical muscle controller and pacing with hemodynamic enhancement
US20090062893 *Mar 16, 2006Mar 5, 2009Meta Cure LimitedPancreas lead
US20090088816 *Mar 18, 2005Apr 2, 2009Tami HarelGastrointestinal Methods And Apparatus For Use In Treating Disorders And Controlling Blood Sugar
US20090292324 *Dec 9, 2005Nov 26, 2009Benny RoussoProtein activity modification
US20100016923 *May 4, 2006Jan 21, 2010Impulse Dynamics NvProtein activity modification
US20110093028 *Oct 25, 2010Apr 21, 2011Impulse Dynamics NvApparatus and method for delivering electrical signals to modify gene expression in cardiac tissue
Classifications
U.S. Classification607/9
International ClassificationA61N1/32, A61B17/00, A61B17/02, A61N1/368, A61N1/365, A61N1/36, A61N1/362
Cooperative ClassificationA61N1/3956, A61N1/36514, A61N1/36557, A61N1/3627, A61B2017/0243, A61N1/36564, A61N1/32, A61B2017/00243, A61N1/368, A61N1/3621
European ClassificationA61N1/362C, A61N1/365B9, A61N1/32, A61N1/365B, A61N1/362A, A61N1/39, A61N1/362